Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the updraftplus domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/abacusv/public_html/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the all-in-one-wp-security-and-firewall domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/abacusv/public_html/wp-includes/functions.php on line 6114
portfolio-details - ABACUS

JUSTIN CHAN

CO-FOUNDER & CEO, GENSE

ABACUS provided an unparalleled level of support, exceeding my expectations as a venture capitalist. This included comprehensive assistance, active sharing of investor networks, periodic meetings, and guidance towards various development opportunities. Through regular communication, we have exchanged a plethora of valuable ideas, attesting to their dedication to fostering technological innovation and their enthusiasm for exploring and pursuing novel ideas.

GENSE

WWW.GENSETECHNOLOGIES.COM

#HEALTH-TECH
#AI DIAGNOSTIC SOLUTIONS

“Start your endeavors early and embrace trial and error. As long as your goals align with your personal beliefs, make the maximum effort and commitment.” – Justin Chan

GENSE TECHNOLOGIES’ portable, self-service medical imaging devices provide a cost-effective solution to preventative screening and chronic disease monitoring.

Used in both home and clinical settings, the company’s devices enable early detection and management of chronic liver, lung, and kidney diseases, which are among the costliest conditions to detect and monitor.

The team behind the award-winning start-up comprises 15 researchers from prestigious institutions including Stanford University, Cambridge University, and the Hong Kong University of Science and Technology. The company has also established partnerships with numerous universities and international life science and technology institutions for clinical trials and engineering research.

Thanks to GENSE TECHNOLOGIES’ devices, imaging scans can be performed at a patient’s home without requiring significant professional training. The device system uses cloud machine learning algorithms to generate results. Currently, GENSE TECHNOLOGIES’ equipment has been adopted by the Hong Kong government and deployed in public hospitals for remote monitoring of recovered COVID-19 patients.

Healthcare distributors from over 20 worldwide markets have also approached the company to use its devices locally, including private hospital networks, clinic chains, health insurance companies, and multinational groups.